MENU
GALT
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Galectin Therapeutics (GALT) Ownership - Who owns Galectin Therapeutics?
Industry: @Biotechnology
Profile
Industry
Biotechnology
Address
4960 Peachtree Industrial Boulevard
Phone
+1 678 620-3186
Employees
14
Web
https://www.galectintherapeutics.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
133.06M
P/E Ratio
N/A
Total Cash
27.06M
Projected Growth
N/A
Total Debt
104.59M
Revenue
N/A
Risk (Beta)
0.03
Dividend Yield
N/A
Total Cash/Share
0.43
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
GALT
Capitalization
133M
P/E Ratio
N/A
Risk (Beta)
0.03
Dividend Yield
N/A
Total Cash
27.1M
Total Cash/Share
0.43
Total Debt
105M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
-94.7M
P/B Ratio
N/A
Cash Flow
N/A
Earnings
-0.73
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
62K
Current Ratio
1.13
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-40.38M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-176.90
Shares Held By Institutions
34.1M
Shares Outstanding - Current
62.8M
Total Liabilities
121M
Total Volume MTD
N/A
Value
-1
Gain YTD
27.711
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of drugs to combat various diseases
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
4960 Peachtree Industrial Boulevard
Phone
+1 678 620-3186
Employees
14
Web
https://www.galectintherapeutics.com